Vesal Yaghoobi

904 total citations
20 papers, 330 citations indexed

About

Vesal Yaghoobi is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vesal Yaghoobi has authored 20 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vesal Yaghoobi's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (6 papers) and Ferroptosis and cancer prognosis (4 papers). Vesal Yaghoobi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (6 papers) and Ferroptosis and cancer prognosis (4 papers). Vesal Yaghoobi collaborates with scholars based in United States, Greece and Spain. Vesal Yaghoobi's co-authors include David L. Rimm, Sandra Martínez-Morilla, Aileen I. Fernandez, Myrto Moutafi, Yalai Bai, Thazin Nwe Aung, Patricia Gaule, Jon Zugazagoitia, Charles T. Robbins and D.C. Liebler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Vesal Yaghoobi

20 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesal Yaghoobi United States 10 197 88 87 79 67 20 330
Mengwan Wu China 11 184 0.9× 60 0.7× 148 1.7× 71 0.9× 77 1.1× 19 415
Kyoungyul Lee South Korea 9 200 1.0× 34 0.4× 96 1.1× 88 1.1× 74 1.1× 18 345
Myrto Moutafi United States 12 311 1.6× 98 1.1× 172 2.0× 98 1.2× 121 1.8× 34 519
Peiling Tsou United States 5 156 0.8× 172 2.0× 106 1.2× 53 0.7× 42 0.6× 6 340
Roland Stein Germany 11 278 1.4× 167 1.9× 105 1.2× 73 0.9× 46 0.7× 17 475
Lin Shui China 8 138 0.7× 32 0.4× 135 1.6× 75 0.9× 72 1.1× 15 307
Daniel Schmolze United States 11 213 1.1× 51 0.6× 69 0.8× 55 0.7× 130 1.9× 30 369
Min‐Sun Jin South Korea 13 126 0.6× 40 0.5× 165 1.9× 119 1.5× 77 1.1× 32 457
Leigh J. Hodson Australia 7 178 0.9× 109 1.2× 79 0.9× 28 0.4× 57 0.9× 9 321
Ayush Pant United States 9 142 0.7× 131 1.5× 109 1.3× 26 0.3× 40 0.6× 15 300

Countries citing papers authored by Vesal Yaghoobi

Since Specialization
Citations

This map shows the geographic impact of Vesal Yaghoobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesal Yaghoobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesal Yaghoobi more than expected).

Fields of papers citing papers by Vesal Yaghoobi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesal Yaghoobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesal Yaghoobi. The network helps show where Vesal Yaghoobi may publish in the future.

Co-authorship network of co-authors of Vesal Yaghoobi

This figure shows the co-authorship network connecting the top 25 collaborators of Vesal Yaghoobi. A scholar is included among the top collaborators of Vesal Yaghoobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesal Yaghoobi. Vesal Yaghoobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aung, Thazin Nwe, Jonathan Warrell, Sandra Martínez-Morilla, et al.. (2024). Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma. Clinical Cancer Research. 30(16). 3520–3532. 6 indexed citations
2.
Aung, Thazin Nwe, Niki Gavrielatou, Aileen I. Fernandez, et al.. (2023). Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non–small Cell Lung Cancer. Cancer Research Communications. 3(3). 471–482. 2 indexed citations
3.
Moutafi, Myrto, Charles T. Robbins, Vesal Yaghoobi, et al.. (2022). Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Laboratory Investigation. 102(10). 1101–1108. 91 indexed citations
4.
Moutafi, Myrto, Sandra Martínez-Morilla, Prajan Divakar, et al.. (2022). Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling. Journal of Thoracic Oncology. 17(8). 991–1001. 23 indexed citations
5.
Shafi, Saba, Thazin Nwe Aung, Charles T. Robbins, et al.. (2022). Development of an immunohistochemical assay for Siglec-15. Laboratory Investigation. 102(7). 771–778. 12 indexed citations
6.
7.
Shafi, Saba, Thazin Nwe Aung, Niki Gavrielatou, et al.. (2022). Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation. 102(10). 1143–1149. 13 indexed citations
8.
Aung, Thazin Nwe, Saba Shafi, James S. Wilmott, et al.. (2022). Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. EBioMedicine. 82. 104143–104143. 25 indexed citations
9.
Yeung, Jacky T., Vesal Yaghoobi, Danielle Miyagishima, et al.. (2021). Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas. Neuro-Oncology. 23(11). 1922–1935. 40 indexed citations
10.
Yaghoobi, Vesal, Myrto Moutafi, Thazin Nwe Aung, et al.. (2021). Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study. Breast Cancer Research. 23(1). 113–113. 6 indexed citations
11.
Psyrri, Amanda, Myrto Moutafi, Georgia-Angeliki Koliou, et al.. (2021). Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 39(15_suppl). 6064–6064. 2 indexed citations
12.
Yaghoobi, Vesal, Aileen I. Fernandez, Jodi Weidler, et al.. (2021). Abstract PS2-03: Comparison of pathologist reads of sp142 and sp263 with quantitative measurement of protein and mRNA in triple negative breast cancer. Cancer Research. 81(4_Supplement). PS2–3. 1 indexed citations
13.
Moutafi, Myrto, Sandra Martínez-Morilla, Prajan Divakar, et al.. (2021). 240 Discovery of biomarkers of resistance to immune checkpoint blockade in non-small-cell lung cancer (NSCLC) using high-plex digital spatial profiling. Regular and Young Investigator Award Abstracts. A258–A258. 1 indexed citations
14.
Yeung, Jacky T., Vesal Yaghoobi, Thazin Nwe Aung, et al.. (2021). Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas. Journal of Neuropathology & Experimental Neurology. 80(2). 150–159. 12 indexed citations
15.
16.
Martínez-Morilla, Sandra, et al.. (2020). Antibody Validation for Protein Expression on Tissue Slides: A Protocol for Immunohistochemistry. BioTechniques. 69(6). 461–469. 32 indexed citations
17.
O’Meara, Tess A., Michał Marczyk, Tao Qing, et al.. (2020). Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers. JCO Precision Oncology. 4(4). 767–779. 32 indexed citations
18.
Yaghoobi, Vesal, Sandra Martínez-Morilla, Yuting Liu, et al.. (2020). Advances in quantitative immunohistochemistry and their contribution to breast cancer. Expert Review of Molecular Diagnostics. 20(5). 509–522. 14 indexed citations
19.
O’Meara, Tess A., Michał Marczyk, Kim Blenman, et al.. (2019). Immunological differences between immune-rich estrogen receptor-positive and -negative breast cancers. Annals of Oncology. 30. v60–v61. 1 indexed citations
20.
Farshchian, Moein, Maryam Moghaddam Matin, Olivier Armant, et al.. (2018). Suppression of dsRNA response genes and innate immunity following Oct4, Stella, and Nanos2 overexpression in mouse embryonic fibroblasts. Cytokine. 106. 1–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengwan Wu Breakdown of academic impact, for papers by Kyoungyul Lee Breakdown of academic impact, for papers by Myrto Moutafi Breakdown of academic impact, for papers by Peiling Tsou Breakdown of academic impact, for papers by Roland Stein Breakdown of academic impact, for papers by Lin Shui Breakdown of academic impact, for papers by Daniel Schmolze Breakdown of academic impact, for papers by Min‐Sun Jin Breakdown of academic impact, for papers by Leigh J. Hodson Breakdown of academic impact, for papers by Ayush Pant
Rankless by CCL
2026